您的位置：
首页
>
农业专利
>
详情页
IMMUNOTHERAPY WITH BINDING AGENTS
专利权人:
发明人:
申请号：
EP13861068.8
公开号：
EP2928483A2
申请日:
2013.12.04
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
Binding agents that modulate the immune response are disclosed. The binding agents may include soluble receptors, polypeptides, and/or antibodies. Also disclosed are methods of using the binding agents for the treatment of diseases such as cancer.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE
USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE
ADJUVANT IMMUNOTHERAPY FOR THE PREVENTIVE, CURATIVE OR PALLIATIVE TREATMENT OF CHRONIC SYSTEMIC DISEASES SUCH AS CANCER, OF CLINICAL MANIFESTATIONS ASSOCIATED WITH THESE DISEASES, SUCH AS CACHEXIA, AND REMEDYING ADVERSE EFFECTS OF DRUGS AND TREATMENTS, SUCH AS IMMUNODEPRESSION, NEUTROPENIA AND LYMPHOCYTOPENIA, COMPRISING THE ASSOCIATION OR COMBINATION OF A SPECIALLY SELECTED BIOLOGICAL RESPONSE MODIFIER AND OTHER ANTINEOPLASTIC COMPOUNDS AND/OR OTHER TREATMENTS
ADJUVANT IMMUNOTHERAPY FOR THE PREVENTIVE, CURATIVE OR PALLIATIVE TREATMENT OF CHRONIC SYSTEMIC DISEASES SUCH AS CANCER, OF CLINICAL MANIFESTATIONS ASSOCIATED WITH THESE DISEASES, SUCH AS CACHEXIA, AND REMEDYING ADVERSE EFFECTS OF DRUGS AND TREATMENTS, SUCH AS IMMUNODEPRESSION, NEUTROPENIA AND LYMPHOCYTOPENIA, COMPRISING THE ASSOCIATION OR COMBINATION OF A SPECIALLY SELECTED BIOLOGICAL RESPONSE MODIFIER AND OTHER ANTINEOPLASTIC COMPOUNDS AND/OR OTHER TREATMENTS
COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE
